Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Amortizatization of Intangibles: 2022-2025

Historic Amortizatization of Intangibles for Fennec Pharmaceuticals (FENC) over the last 4 years, with Sep 2025 value amounting to $26,000.

  • Fennec Pharmaceuticals' Amortizatization of Intangibles rose 4.00% to $26,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $103,000, marking a year-over-year decrease of 86.95%. This contributed to the annual value of $800,000 for FY2024, which is 1112.12% up from last year.
  • Per Fennec Pharmaceuticals' latest filing, its Amortizatization of Intangibles stood at $26,000 for Q3 2025, which was up 4.00% from $25,000 recorded in Q2 2025.
  • In the past 5 years, Fennec Pharmaceuticals' Amortizatization of Intangibles ranged from a high of $723,000 in Q1 2024 and a low of $1,000 during Q1 2022.
  • Over the past 3 years, Fennec Pharmaceuticals' median Amortizatization of Intangibles value was $25,000 (recorded in 2025), while the average stood at $85,727.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first surged by 3,515.00% in 2024, then slumped by 96.40% in 2025.
  • Quarterly analysis of 4 years shows Fennec Pharmaceuticals' Amortizatization of Intangibles stood at $15,000 in 2022, then remained steady at $15,000 in 2023, then spiked by 73.33% to $26,000 in 2024, then climbed by 4.00% to $26,000 in 2025.
  • Its Amortizatization of Intangibles was $26,000 in Q3 2025, compared to $25,000 in Q2 2025 and $26,000 in Q1 2025.